03 Profile
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Respiratory (asthma/COPD)
Michalis Papadakis
CEO and Co-Founder of Brainomix
press citation on 1 topic since 15 Oct 2026 · last quoted 15 Oct 2026
02 Quoted on · 1 of 29 topics
Michalis Papadakis: key facts
- Kind of voice
- Academic
- Role
- CEO and Co-Founder of Brainomix
- Quoted on
- Respiratory (asthma/COPD)
- Tracked press citations
- 1
- Most recently quoted
- 15 Oct 2026
04 On the record · press
What Michalis Papadakis has said
- scientistlive.com1
Where Michalis Papadakis has been quoted
- 01Brainomix partnership brings patient perspectives to AI-powered pulmonary fibrosis care - Scientist Livescientistlive.com · 15 Oct 2026
Verbatim
“Patients are at the heart of everything we are trying to achieve with e-Lung, while our technology can provide new imaging tools for lung disease, we need to understand how those tools inform clinical understanding and how that information is communicated to and understood by the people living with the disease.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.